Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis

M. A. Yates, Y. Li, P. Chlebeck, T. Proctor, Arthur Vandenbark, Halina Offner

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Ovarian hormones, including progesterone, are known to have immunomodulatory and neuroprotective effects which may alter the disease course of experimental autoimmune encephalomyelitis (EAE). In the current study, we examined the treatment potential of progesterone beginning at the onset of EAE symptoms. Progesterone treated animals showed reduced peak disease scores and cumulative disease indices, and decreased inflammatory cytokine secretion (IL-2 and IL-17). In addition, increased production of IL-10 was accompanied by increased numbers of CD19+ cells and an increase in CD8+ cells. Decreased chemokine and chemokine receptor expression in the spinal cord also contributed to decreased lesions in the spinal cord.

Original languageEnglish (US)
Pages (from-to)136-139
Number of pages4
JournalJournal of Neuroimmunology
Volume220
Issue number1-2
DOIs
StatePublished - Mar 30 2010

Fingerprint

Autoimmune Experimental Encephalomyelitis
Interleukin-10
Progesterone
Spinal Cord
Interleukin-17
Chemokine Receptors
Neuroprotective Agents
Chemokines
Interleukin-2
Cell Count
Hormones
Cytokines

Keywords

  • B cells
  • EAE
  • Estrogen
  • Multiple sclerosis
  • Progesterone

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. / Yates, M. A.; Li, Y.; Chlebeck, P.; Proctor, T.; Vandenbark, Arthur; Offner, Halina.

In: Journal of Neuroimmunology, Vol. 220, No. 1-2, 30.03.2010, p. 136-139.

Research output: Contribution to journalArticle

@article{310dc7f15351460fb80f1a1b39a377a2,
title = "Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis",
abstract = "Ovarian hormones, including progesterone, are known to have immunomodulatory and neuroprotective effects which may alter the disease course of experimental autoimmune encephalomyelitis (EAE). In the current study, we examined the treatment potential of progesterone beginning at the onset of EAE symptoms. Progesterone treated animals showed reduced peak disease scores and cumulative disease indices, and decreased inflammatory cytokine secretion (IL-2 and IL-17). In addition, increased production of IL-10 was accompanied by increased numbers of CD19+ cells and an increase in CD8+ cells. Decreased chemokine and chemokine receptor expression in the spinal cord also contributed to decreased lesions in the spinal cord.",
keywords = "B cells, EAE, Estrogen, Multiple sclerosis, Progesterone",
author = "Yates, {M. A.} and Y. Li and P. Chlebeck and T. Proctor and Arthur Vandenbark and Halina Offner",
year = "2010",
month = "3",
day = "30",
doi = "10.1016/j.jneuroim.2010.01.013",
language = "English (US)",
volume = "220",
pages = "136--139",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis

AU - Yates, M. A.

AU - Li, Y.

AU - Chlebeck, P.

AU - Proctor, T.

AU - Vandenbark, Arthur

AU - Offner, Halina

PY - 2010/3/30

Y1 - 2010/3/30

N2 - Ovarian hormones, including progesterone, are known to have immunomodulatory and neuroprotective effects which may alter the disease course of experimental autoimmune encephalomyelitis (EAE). In the current study, we examined the treatment potential of progesterone beginning at the onset of EAE symptoms. Progesterone treated animals showed reduced peak disease scores and cumulative disease indices, and decreased inflammatory cytokine secretion (IL-2 and IL-17). In addition, increased production of IL-10 was accompanied by increased numbers of CD19+ cells and an increase in CD8+ cells. Decreased chemokine and chemokine receptor expression in the spinal cord also contributed to decreased lesions in the spinal cord.

AB - Ovarian hormones, including progesterone, are known to have immunomodulatory and neuroprotective effects which may alter the disease course of experimental autoimmune encephalomyelitis (EAE). In the current study, we examined the treatment potential of progesterone beginning at the onset of EAE symptoms. Progesterone treated animals showed reduced peak disease scores and cumulative disease indices, and decreased inflammatory cytokine secretion (IL-2 and IL-17). In addition, increased production of IL-10 was accompanied by increased numbers of CD19+ cells and an increase in CD8+ cells. Decreased chemokine and chemokine receptor expression in the spinal cord also contributed to decreased lesions in the spinal cord.

KW - B cells

KW - EAE

KW - Estrogen

KW - Multiple sclerosis

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=77649178742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649178742&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2010.01.013

DO - 10.1016/j.jneuroim.2010.01.013

M3 - Article

VL - 220

SP - 136

EP - 139

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -